SCHEMBL4928564

SCHEMBL4928564

FC(F)C(F)(F)Oc1ccc(-n2c(Cl)nc3ccc(Cl)cc32)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 2/20 0.38
DHODH Q02127 1/20 0.34
PDE2A O00408 3/20 0.34
PRKCA P17252 1/20 0.34
RAB9A P51151 2/20 0.33
GSR P00390 1/20 0.33
PDE10A Q9Y233 1/20 0.33
MEN1 O00255 1/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33
MAT2A P31153 1/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
PAX8 Q06710 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
AHR P35869 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4931175 0.88 DHODH (0.44) DHODHRAB9AMAPTNPC1LMNA
SCHEMBL4929868 0.81 DRD2 (0.43) LMNA
SCHEMBL4933013 0.80 PDE2A (0.38) PDE2ARAB9AGSRMEN1MAPT
SCHEMBL4931125 0.79 CYP19A1 (0.48) PDE2ARAB9APDE10AMEN1MAPT
SCHEMBL4927317 0.76 P2RX3 (0.41) TRPV1RAB9AMAPTKMT2ANPC1
Hydrochloric Acid SCHEMBL4930110 0.75 P2RX3 (0.41) TRPV1RAB9AMAPTKMT2ANPC1
SCHEMBL4922183 0.75 CACNA2D1 (0.47) MEN1MAPTKMT2ANPC1ALDH1A1
SCHEMBL4929926 0.74 L3MBTL1 (0.44) DHODHPDE2AMAPTPOLBL3MBTL1
SCHEMBL4927269 0.73 CACNA2D1 (0.48) DHODHPDE2APDE10AMAPTLMNA
SCHEMBL4921791 0.73 PDE2A (0.49) DHODHPDE2ARAB9APDE10AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080021069-A1 Receptor Function Regulating Agent TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-24 US disclosed
EP-1810677-A1 RECEPTOR FUNCTION REGULATING AGENT Takeda Pharmaceutical Company Limited (JP) 2007-07-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080021069-A1 Receptor Function Regulating Agent GPR119, INSR, GPR65 TRPV1 166/4885DHODH 2783/4885PDE2A 995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.